A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC

NCT06632405 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Camrelizumab
DRUG: Nab paclitaxel
DRUG: Levocetirizine Hydrochloride

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University